Home
On-Demand
Industrie
FAQ
Home
On-Demand
Industrie
FAQ
Schlagwort
Indolente Lymphome
Lymphome
Lymphome
ACVB-OP
/
AMR30
/
DLBCL
/
H10 Studie
/
Hodgkin Lymphom
/
Ibrutinib
/
Indolente Lymphome
/
iNHL
/
Konsensus-Leitlinie
/
Myofibroblasten
/
Orbita Lymphom
/
Panzytopenie
/
Procarbazin
/
RAPID Studie
/
S3-Leitlinie
/
UNFOLDER Studie
/
VMAT-RT
Lymphome
Lymphome
ABVD
/
Aggressive Lymphome
/
ALLG NHL15
/
American Radium Society
/
AMR30
/
Chemotherapie
/
DLBCL
/
EFS
/
Erstlinientherapie
/
FIL HD0801
/
Gesamtüberleben
/
GOELAMS
/
Hodgkin Lymphom
/
Indolente Lymphome
/
Lokalrezidiv
/
LYSA
/
Malignome
/
MZL
/
National Clinic Trials
/
NCRI-RAPID
/
Network Study S1001
/
Pembrolizumab
/
PET
/
PFS
/
PMBCL
/
Protonentherapie
/
R-CHOP
/
Radiotherapie
/
TROG 05.02
